Knowledge Center

Patent / Jun 29, 2017

Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition

Authors:
  • Mohammad Salman
  • Arturo Angel
  • Vijaya Swaminathan
  • George Magrath
Source:
US 20170182071 A1 20170629

The invention relates to a topical suspension formulation that includes a tetracycline, a liq. medium and a polymeric gelling agent. The tetracycline may be in the form of its pharmaceutically acceptable salts, hydrates, or polymorphs and is in a suspended form within the formulation. The liq. medium is selected such that it does not dissolve or substantially minimally dissolves the tetracycline. The gelling agent is a polymeric hydrocarbon gelling agent. Preferably, the tetracycline has a particle size of less than or equal to about 20 μ.

Also in the Knowledge Center

Related Content

Process Analytical Technology

To better understand and control processes.

Page
Read more

Drug Product Manufacturing

To extend ËÄÉ«AV further we are now able to offer clinical supplies manufacturing for drug products.

Page
Read more

ASD-HIPROS

ASD-HIPROS, ËÄÉ«AV’s Intelligent Proprietary Screening, is the most advanced and accurate tool to identify Amorphous Solid Dispersion formulations by Spray Drying with maximum performance and stability.

Page
Read more